Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE 2025, 3 (1). https://doi.org/10.52465/johmpe.v3i1.547.